These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19252243)

  • 1. [Molecular mechanism of bone destruction].
    Inoue H; Takayanagi H
    Clin Calcium; 2009 Mar; 19(3):339-46. PubMed ID: 19252243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteoclast differentiation and activation].
    Takayanagi H
    Clin Calcium; 2007 Apr; 17(4):484-92. PubMed ID: 17404476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms of bone destruction in rheumatoid arthritis].
    Nanki T
    Clin Calcium; 2007 Apr; 17(4):510-6. PubMed ID: 17404479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclasts in arthritis and Th17 cell development.
    Okamoto K; Takayanagi H
    Int Immunopharmacol; 2011 May; 11(5):543-8. PubMed ID: 21081190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis.
    Udagawa N
    J Bone Miner Metab; 2003; 21(6):337-43. PubMed ID: 14586789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bone destruction and osteoimmunology.
    Takayanagi H
    J Periodontal Res; 2005 Aug; 40(4):287-93. PubMed ID: 15966905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclasts, rheumatoid arthritis, and osteoimmunology.
    Sato K; Takayanagi H
    Curr Opin Rheumatol; 2006 Jul; 18(4):419-26. PubMed ID: 16763464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune regulation of bone loss by Th17 cells.
    Adamopoulos IE; Bowman EP
    Arthritis Res Ther; 2008; 10(5):225. PubMed ID: 18983698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RANKL as a target molecule for treatment of joint destruction].
    Tanaka S
    Clin Calcium; 2007 Apr; 17(4):586-92. PubMed ID: 17404489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of osteoclast differentiation induced by IL-1.
    Kim JH; Jin HM; Kim K; Song I; Youn BU; Matsuo K; Kim N
    J Immunol; 2009 Aug; 183(3):1862-70. PubMed ID: 19587010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.
    Sato K; Suematsu A; Okamoto K; Yamaguchi A; Morishita Y; Kadono Y; Tanaka S; Kodama T; Akira S; Iwakura Y; Cua DJ; Takayanagi H
    J Exp Med; 2006 Nov; 203(12):2673-82. PubMed ID: 17088434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dynamic interplay between osteoclasts and the immune system.
    Nakashima T; Takayanagi H
    Arch Biochem Biophys; 2008 May; 473(2):166-71. PubMed ID: 18410741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoimmunology.
    Rauner M; Sipos W; Pietschmann P
    Int Arch Allergy Immunol; 2007; 143(1):31-48. PubMed ID: 17191007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of bone destruction and the contribution of T lymphocytes].
    Komatsu N
    Nihon Rinsho; 2016 Jun; 74(6):907-12. PubMed ID: 27311177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
    Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
    J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular determinants in osteoclast differentiation and osteoimmunology].
    Takayanagi H
    Rinsho Ketsueki; 2009 Jun; 50(6):447-52. PubMed ID: 19571503
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
    Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
    Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone and cartilage destruction in rheumatoid arthritis].
    Komatsu N; Takayanagi H
    Clin Calcium; 2012 Feb; 22(2):179-85. PubMed ID: 22298070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation.
    Negishi-Koga T; Takayanagi H
    Immunol Rev; 2009 Sep; 231(1):241-56. PubMed ID: 19754901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoimmunology update--from bench to bedside].
    Takayanagi H
    Nihon Rinsho; 2009 May; 67(5):1031-7. PubMed ID: 19432129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.